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Abstract: Thymidylate synthase (TS) is an enzyme of paramount importance as it provides the only
de novo source of deoxy-thymidine monophosphate (dTMP). dTMP, essential for DNA synthesis, is
produced by the TS-catalyzed reductive methylation of 2′-deoxyuridine-5′-monophosphate (dUMP)
using N5,N10-methylenetetrahydrofolate (mTHF) as a cofactor. TS is ubiquitous and a validated drug
target. TS enzymes from different organisms differ in sequence and structure, but are all obligate
homodimers. The structural and mechanistic differences between the human and bacterial enzymes
are exploitable to obtain selective inhibitors of bacterial TSs that can enrich the currently available
therapeutic tools against bacterial infections. Enterococcus faecalis is a pathogen fully dependent on TS
for dTMP synthesis. In this study, we present four new crystal structures of Enterococcus faecalis and
human TSs in complex with either the substrate dUMP or the inhibitor FdUMP. The results provide
new clues about the half-site reactivity of Enterococcus faecalis TS and the mechanisms underlying
the conformational changes occurring in the two enzymes. We also identify relevant differences in
cofactor and inhibitor binding between Enterococcus faecalis and human TS that can guide the design
of selective inhibitors against bacterial TSs.
Keywords: thymidylate synthase; Enterococcus faecalis; half-site reactivity; x-ray structure; selectivity
1. Introduction
Thymidylate synthase (TS, EC 2.1.1.45) is a ubiquitous enzyme that catalyzes the reductive
methylation of 2′-deoxyuridine-5′-monophosphate (dUMP) to 2′-deoxythymidyne-5′-monophosphate
(dTMP) using N5,N10-methylenetetrahydrofolate (mTHF) as a cofactor. In cells, TS provides the only
synthetic source of dTMP necessary for DNA biosynthesis. Indeed, TS inhibition halts the replication
processes and induces apoptosis in rapidly dividing cells, which is an effect known as “thymineless
death” [1]. Given its pivotal role in cell survival and proliferation, TS represents a validated target
in anticancer and antibacterial chemotherapy; even though some bacteria express a further enzyme,
the flavin dependent TS (FDTS), that is able to catalyze the same reaction. FDTS requires flavin
adenine dinucleotide (FAD) and nicotinamide adenine dinucleotide phosphate (NADPH) to perform
its action [2]. Important human pathogens, including Bacillus anthracis, Clostridium botulinum, and
Mycobacterium species, encode for both TS and FDTS [2]. In other pathogenic strains, such as
Enterococcus faecalis, only TS has been identified [2]. The development of TS inhibitors that can
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be used alone or in combination with FDTS targeting molecules is a promising strategy to generate
new effective antibacterial drugs.
TS works as an obligate homodimer, having residues from both enzyme subunits that contribute to
substrate binding in each catalytic site. TS subunits are characterized by two domains, known as large
and small domains (LD and SD, respectively). The LD, showing a mixed α/β structure, represents the
conserved core of the enzyme, whereas the SD is highly variable (in extension and structure) among
the different organisms. The structures of TSs from various sources have been elucidated. Among
them, only those from Enterococcus faecalis (Ef TS) and humans (hTS) have shown relevant domain
changes that have been connected with different functional states of the enzymes (Figure 1) [3–5]. hTS
switches between the active and inactive conformation through extended structural rearrangements
that involve the catalytic loop (residues 181–197) [3,6]. In the active conformation, the catalytic Cys195
participates in the enzyme active site, whereas in the inactive conformation, it is exposed on the dimer
interface (Figure 1a). On the other hand, Ef TS is characterized by the transition between the closed
and open states (Figure 1b) [5]. In the former, the SD (residues 69–138) is fully ordered and contributes
to create the cofactor binding site, whereas, in the latter, it is highly flexible and allows opening
of the catalytic cavity (Figure 1b). Differently from the human enzyme, the open and closed states
were identified within the same Ef TS homodimer, leading to asymmetry between the two enzyme
subunits [5]. This phenomenon is related to the so-called “half-site reactivity”, whose presence in
all forms of TS is still matter of debate [7,8]. The transitions to the closed state in Ef TS, and to the
active conformation in hTS, are fundamental to create functional active sites in which dUMP can bind,
followed by the cofactor [3,5]. According to the reaction mechanism, the thiol of the conserved catalytic
cysteine (Cys197 and Cys195, in Ef TS and hTS, respectively) attacks the carbon atom in position 6 (C6)
on the nucleotide pyrimidine base. This leads to the formation of a covalent adduct (Scheme 1) [9,10].
The dUMP uracil carbon in position 5 (C5) is then activated to accept the methyl moiety (C11) and the
hydride donated by mTHF.
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Figure 1. (a) Cartoon representation of the hTS homodimer in the active (PDB id 1HVY [3]) and 
inactive conformations (PDB id 1YPV [4]; for the inactive conformation, only the catalytic loop, 
including residues 181–197, is shown for clarity). In both subunits, the large and small domains are 
coloured light pink and dark pink, respectively. The two orientations of the catalytic loop (residues 
181–197), defining the active (brown trace, PDB id 1HVY [3]) and inactive (green trace, PDB id 1YPV 
[4]) enzyme conformations, are displayed. The catalytic cysteine is shown in sticks (brown and green 
carbons in the active and inactive conformations, respectively). The position of the catalytic cavity is 
indicated by the presence of the substrate 2’-deoxyuridine 5’-monophosphate (dUMP, in sticks, black 
carbons). (b) Cartoon representation of the EfTS homodimer (PDB id 3UWL [5]). In both subunits, the 
large and small domains are coloured white and dark pink, respectively. The large domain (residues 
1–68 and 139–315), representing the conserved core of the enzyme, shows an α/β structure generated 
by seven α-helices and eight β-strands. The small domain (residues 69–138) are only fully structured 
(five α-helices connected by short loops) in the enzyme subunit with the cofactor binding site 
populated by 5-formyl-6-tetrahydrofolate (5-FTHF, in sticks, purple carbons). In the partner subunit, 
the small domain is highly flexible and only partially visible in the structures. The position of the 
active site is indicated by the catalytic Cys197 (in sticks, white carbons; in subunit B, it is modified as 
S,S-(2-hydroxyethyl)thiocysteine, CME197). In all figures, nitrogen atoms are coloured blue, oxygen 
red, sulphur yellow, and phosphorous magenta. 
Figure 1. (a) Carto n representation of t i er in the active (PDB id 1HVY [3]) and
inactive conformations (PDB id 1YPV [4]; for the inactive conformation, only the catalytic loop,
including residues 181–197, is shown for clarity). In both subunits, the large and small domains are
coloured light pink and dark pink, respectively. The two orientations of the catalytic loop (residues
181–197), defining the active (brown trace, PDB id 1HVY [3]) and inactive (green trace, PDB id 1YPV [4])
enzyme conformations, are displayed. The catalytic cysteine is shown in sticks (brown and green
carbons in the active and inactive conformations, respectively). The position of the catalytic cavity
is indicated by the presence of the substrate 2′-deoxyuridine 5′-monophosphate (dUMP, in sticks,
black carbons). (b) Cartoon representation of the Ef TS homodimer (PDB id 3UWL [5]). In both
subunits, the large and small domains are coloured white and dark pink, respectively. The large
domain (residues 1–68 and 139–315), representing the conserved core of the enzyme, shows an α/β
structure generated by seven α-helices and eight β-strands. The small domain (residues 69–138) are
only fully structured (five α-helices connected by short loops) in the enzyme subunit with the cofactor
binding site populated by 5-formyl-6-tetrahydrofolate (5-FTHF, in sticks, purple carbons). In the partner
subunit, the small domain is highly flexible and only partially visible in the structures. The position of
the active site is indicated by the catalytic Cys197 (in sticks, white carbons; in subunit B, it is modified
as S,S-(2-hydroxyethyl)thiocysteine, CME197). In all figures, nitrogen atoms are coloured blue, oxygen
red, sulphur yellow, and phosphorous magenta.
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Scheme 1. Proposed reaction scheme for the TS catalyzed reaction. Adapted from [9,10]. 
In the present work, we report the structural characterization of EfTS in complex with the 
substrate dUMP and its analogue 5-fluoro-2’-deoxyuridine-5’-monophosphate (FdUMP). FdUMP is 
a known potent TS inhibitor [11], for which we measured a Ki towards EfTS in the nM range. In both 
structures, dUMP and FdUMP populate only one catalytic cavity of the enzyme dimer, providing 
new evidence to support the half-site reactivity model proposed for this TS enzyme [5]. Furthermore, 
the comparison with the structure of native EfTS shows that substantial changes are induced by 
substrate binding. The structural analysis was also extended to the human enzyme (48 % sequence 
identity), reporting its characterization in complex with the same molecules. Even though former 
studies described the interactions of FdUMP within the hTS active site [12,13], we observe significant 
differences in the inhibitor binding mode. The structural information achieved provides new clues to 
explain the mechanisms guiding the conformational switches in these enzymes, highlighting a 
prominent role of the dimer interface in inter-subunit communication. Furthermore, the structural 
comparison of human and EfTS shows the presence of non-conserved residues in their catalytic 
cavities, mainly involved in cofactor binding. This information is of key importance for the rational 
development of inhibitors able to selectively target EfTS without altering the activity of the 
counterpart enzyme in the human host. 
2. Results and Discussion 
2.1. EfTS in Complex with the Substrate dUMP and Its Analogue FdUMP 
2.1.1. EfTS Overall Fold 
EfTS has the constitutive dimeric quaternary structure typical of all TS enzymes [14]. The two 
independent EfTS dimers (A-B and C-D), present in the cell asymmetric unit (ASU), have essentially 
identical structures and show structural heterogeneity between subunits due to asymmetric ligand 
binding within the enzyme active sites (Figure 2). The structure of the “as prepared” EfTS (PDB id 
3UWL), formerly characterized by us, revealed the presence of a folate derivative, constitutively 
populating one active site within each EfTS homodimer [5]. This cofactor analogue, interpreted as 5-
formyl-6-tetrahydrofolate (5-FTHF), copurifies with the enzyme and generates asymmetry between 
the two enzyme protomers (vide infra, Figure 2). 5-FTHF is a metabolite of the folate cycle that 
naturally occurs in the cell [15]. In the homodimer, Arg177 and Arg178 from one EfTS subunit 
participate in the assembly of the active site of the partner subunit. In both complexes, subunits B and 
D are in the closed state, displaying the SD (residues 69–138) fully structured in five α-helices 
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In the present work, we report the structural characterization of Ef TS in complex with the substrate
dUMP and its analogue 5-fluoro-2′-deoxyuridine-5′-monophosphate (FdUMP). FdUMP is a known
potent TS inhibitor [11], for which we measured a Ki towards Ef TS in the nM range. In both structures,
dUMP and FdUMP populate only one catalytic cavity of the enzyme dimer, providing new evidence to
support the half-site reactivity model proposed for this TS enzyme [5]. Furthermore, the comparison
with the structure of native Ef TS shows that substantial changes are induced by substrate binding.
The structural analysis was also extended to the human enzyme (48 % sequence identity), reporting
its characterization in complex with the same molecules. Even though former studies described
the interactions of FdUMP within the hTS active site [12,13], we observe significant differences in
the inhibitor binding mode. The structural information achieved provides new clues to explain the
mechanisms guiding the conformational switches in these enzymes, highlighting a prominent role of
the dimer interface in inter-subunit communication. Furthermore, the structural comparison of human
and Ef TS shows the presence of non-conserved residues in their catalytic cavities, mainly involved in
cofactor binding. This information is of key importance for the rational development of inhibitors able
to selectively target Ef TS without altering the activity of the counterpart enzyme in the human host.
2. Results and Discussion
2.1. EfTS in Complex with the Substrate dUMP and Its Analogue FdUMP
. .1. Ef TS Overall Fold
Ef TS has the constitutive dimeric quaternary structure typical of all TS enzymes [14]. The two
independent Ef TS dimers (A-B and C-D), present in the cell asymmetric unit (ASU), have essentially
identical structures and show structural heterogeneity between subunits due to asymmetric ligand
binding within the enzyme active sites (Figure 2). The structure of the “as prepared” Ef TS (PDB
id 3UWL), formerly characterized by us, revealed the presence of a folate derivative, constitutively
populating one active site within each Ef TS homodimer [5]. This cofactor analogue, interpreted as
5-formyl-6-tetrahydrofolate (5-FTHF), copurifies with the enzyme and generates asymmetry between
the two enzyme protomers (vide infra, Figure 2). 5-FTHF is a metabolite of the folate cycle that naturally
occurs in the cell [15]. In the homodimer, Arg177 and Arg178 from one Ef TS subunit participate in the
assembly of the active site of the partner subunit. In both complexes, subunits B and D are in the closed
state, displaying the SD (residues 69–138) fully structured in five α-helices connected by short loops,
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with the active site hosting the 5-FTHF molecule (Figure 2). On the other hand, the partner subunits (A
and C) adopt the open conformation, showing the SD partially ordered in only three α-helices. Due to
disorder, residues 92–124 and 98–118, in the dUMP and FdUMP complexes, respectively, have been
excluded from our models.
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Figure 2. Dimer of EfTS (large and small domains are represented as grey and dark pink cartoon, 
respectively) in complex with (a) dUMP (in sticks, black carbons) and (b) FdUMP (in sticks, cyan 
carbons). Structural heterogeneity within the functional EfTS dimer is observed in both complexes. In 
the EfTS–dUMP complex, the nucleotide is bound to subunit A, whereas the cofactor-like molecule 5-
formyl-6-tetrahydrofolate (5-FTHF, in sticks, purple carbons) occupies the active site of subunit B in 
which the catalytic cysteine is modified as S,S-(2-hydroxyethyl)thiocysteine (CME197, in sticks, grey 
carbons). On the other hand, in the EfTS–FdUMP complex, the substrate-like inhibitor (in sticks, cyan 
carbons) is bound to subunit B together with the cofactor-like molecule 5-FTHF (in sticks, purple 
carbons). 
Figure 2. Dimer of Ef TS (large and small domains are represented as grey and dark pink cartoon,
respectively) in complex with (a) dUMP (in sticks, black carbons) and (b) FdUMP (in sticks, cyan
carbons). Structural heterogeneity within the functional Ef TS dimer is observed in both complexes. In
the Ef TS–dUMP complex, the nucleotide is bound to subunit A, whereas the cofactor-like molecule
5-formyl-6-tetrahydrofolate (5-FTHF, in sticks, purple carbons) occupies the active site of subunit B
in which the catalytic cysteine is modified as S,S-(2-hydroxyethyl)thiocysteine (CME197, in sticks,
grey carbons). On the other hand, in the Ef TS–FdUMP complex, the substrate-like inhibitor (in sticks,
cyan carbons) is bound to subunit B together with the cofactor-like molecule 5-FTHF (in sticks, purple
carbons).
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2.1.2. Ef TS–dUMP Complex
The structure of Ef TS in complex with the substrate dUMP was determined to be 1.75 Å resolution
(Figure 2, Table S1). The cofactor-analogue (6S)-5-formyl-6-tetrahydrofolate (5-FTHF) is entrapped in
the active sites of subunits B and D by the same tight network of interactions already observed in the
substrate-free form of the enzyme (Figure S1) [5]. Moreover, in these subunits, the catalytic Cys197 is
modified as S,S-(2-hydroxylethyl)thiocysteine (CME197, Figure 2a and Figure S1) by the reaction with
β-mercaptoethanol (added to the protein buffer during the purification process [5]). In the partner
subunits (A and C), the electron density of the catalytic Cys197 suggests that it had been oxidized to
sulfenic acid (S-oxycysteine, CSX197 in Figure 3). Despite the oxidation of Cys197, the substrate dUMP
populates the active site, showing its uracil moiety positioned just above the cysteine sulphur (C6–Sγ
distance of ~3.7 Å) (Figure 3). In both chains, the substrate shows the same network of interactions
(Figure 3). The dUMP phosphate is salt-bridged to Arg22, Arg217, Arg177’, and Arg178’ (the last two
from the partner subunit) and it is further H-bonded to the hydroxyl of Ser218. The dUMP ribose
hydroxyl is H-bonded to His258 and Tyr260. The uracil ketone oxygen in position 2 receives H-bonds
from the backbone nitrogen of Asn220 and the amide nitrogen of Gln216. Furthermore, the amide
moiety of Asn228 donates an H-bond to the uracil ketone in position 4 and receives an H-bond from
the uracil nitrogen in position 3.
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substrate-free subunits of the enzyme (PDB id 3UWL [5]) shows that meaningful changes occur upon 
dUMP binding (Figure 4). The most evident rearrangement concerns the flexible loop 18–26, which 
moves towards the catalytic cavity in the dUMP-bound subunits, exposing Arg22 inside the 
phosphate recognition pocket (Figure 4). The movement of Arg22, whose Cα shifts by ~5.8 Å, is 
fundamental to create the four-arginine cluster that anchors the dUMP phosphate in the substrate 
site. However, this conformation of the 18–26 loop resembles that observed in the closed state of the 
substrate-free enzyme (PDB id 3UWL), where 5-FTHF is bound and in which the four-arginine cluster 
is fully formed and binds a sulfate/phosphate anion [5] (Figure 4). On the contrary, in the subunits of 
Figure 3. Active s t vi w of E TS (white carto carbon atoms) in complex with dUMP (in sticks,
black carbon atoms). In the panel, dUMP is surrounded by the omit en esh) contoured at the
2.5 σ level. Key interactions (salt bridges, hydrogen and halogen bonds) are displayed as tan dashed
lines. The catalytic cysteine is oxidized to sulfenic acid (S-oxycysteine, CSX197), surrounded by the
2Fo-Fc map (blue mesh, contoured at the 1.5 σ level).
While subunits A and C where dUMP is bound display the open conformation, subunits B
and D where 5-FTHF is bound are in the closed conformation. The structural comparison with the
substrate-free subunits of the enzyme (PDB id 3UWL [5]) shows that meaningful changes occur upon
dUMP binding (Figure 4). The most evident rearrangement concerns the flexible loop 18–26, which
moves towards the catalytic cavity in the dUMP-bound subunits, exposing Arg22 inside the pho phate
recognition pocket (Figur 4). The movement of Arg22, whose Cα shifts by ~5.8 Å, is fundamental to
create the four-arginine cluster that anchors the dUMP phosphate in the substrate site. However, this
conformation of the 18–26 loop resembles that observed in the closed state of the substrate-free enzyme
(PDB id 3UWL), where 5-FTHF is bound and in which the four-arginine cluster is fully formed and
binds a sulfate/phosphate anion [5] (Figure 4). On the contrary, in the subunits of the substrate-free
enzyme in the open conformation (subunits A and C of 3UWL), the loop is turned away from the
active site and Arg22 points to the solvent-exposed surface of Ef TS (Figure 4).
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populates the active sites of subunits B and D (Figure 5a) turned to a closed state, whereas chains A 
and C remain in the open conformation typical of ligand-free subunits (Figure 2b) [5]. In subunits B 
and D, FdUMP binding is accompanied by the accommodation of 5-FTHF in the cofactor site (the 
same cofactor analogue also entrapped in the active site of the native enzyme [5]; Figure 5a). FdUMP 
occupies the substrate pocket, where it mimics the dUMP binding mode, forming similar interactions 
within the cavity (Figures 3 and 5a). Nonetheless, the 5-fluoro-uracil moiety of FdUMP is positioned 
closer to the catalytic Cys197 (distance of ~2.7 Å between the inhibitor C6 and the cysteine thiol) 
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catalytic cysteine, observed in the two complexes. Notably, in the dUMP-complex, the Cys197 side 
Figure 4. Structural comparison of the different states observed in the structure of substrate-free Ef TS
(PDB id 3UWL [5], open conformation in gold and closed conformation in light blue) and in its complex
with dUMP (open conformation in white, only the dUMP-bound subunit is shown). The closed
conformation of both SD (circled) and loop 18–26 is observed in subunits B and D of substrate-free Ef TS
(light blue cartoon and carbon atoms) where 5-FTHF is bound. The open conformation of SD and loop
18-26 is observed in chains A and C of the substrate-free enzyme (gold cartoon and carbons). In the
Ef TS–dUMP complex (in white), a closed conformation of loop 18–26 is visible in the dUMP-bound
subunits. In Ef TS, the open/closed transition occurs as a biphasic process in which the dUMP binding
triggers the closure of loop 18–26 (pink dashed arrow), whereas the binding of the cofactor (or analogue)
induces the movement and the organization of the whole SD (purple dashed arrow).
Remarkably, despite the full occupancy of the substrate site by dUMP and the movement of the
18–26 loop towards dUMP, the SD retains the open conformation, in which it is widely unstructured.
This observation strongly suggests that in Ef TS, the open/closed transition occurs as a biphasic process
in which the dUMP accommodation triggers the closure of the loop 18–26, whereas the binding of the
cofactor (or analogue) induces the movement and the organization of the whole SD.
2.1.3. Ef TS–FdUMP Complex
Inhibition assays of Ef TS activity performed n FdUMP r sulted in a Ki of 74 nM. The structure of
Ef TS in complex with the ubstrate alogue FdUMP was etermined at 2.88 Å resolution (Table S1),
consistently showin subunit asymmetry within each nzym dimer (Figure 2b). dUMP populates
the act ve site of subunits B and D (Figure 5a) turned to a closed state, whereas chains A and C remain
in t e open conformation typical of ligand-fr e ubunits (Figure 2b) [5]. In subunits B and D, FdUMP
binding is accompanied by the accommodation of 5-FTHF in the cofactor site ( sam cofact r
analogue also entrapp d in the active site of the native enzyme [5]; Figure 5a). FdUMP occupies t
substrate pocket, where it m mics the dUMP binding mode, forming similar interactions within th
cavity (Figures 3 and 5a). Nonetheless, the 5-fluoro-uracil moiety of FdUMP is positioned closer to
the catalytic Cys197 (distance of ~2.7 Å between the inhibitor C6 and the cysteine thiol) (Figure 5b).
The shortening of this distance is possibly related to the different oxidation states of the catalytic
cysteine, observed in the two complexes. Notably, in the dUMP-complex, the Cys197 side chain is
modified to sulfenic acid, thus blocking the nucleophilic attack of the thiol to the substrate C6. On
the contrary, in the complex with FdUMP, the thiol of Cys197 is reactive and can form a covalent
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adduct with the inhibitor that, indeed, is positioned closer to the catalytic residue. In this arrangement,
the 5-fluorine on the FdUMP uracil moiety is proximal (~2.7 Å) to the Tyr145 hydroxyl, suggesting the
formation of a halogen bond with it [16] (Figure 5a). Moreover, the same moiety of Tyr145 donates an
H-bond to the FdUMP ketone oxygen in position 4, contributing to stabilize the inhibitor within the
catalytic cavity.
Molecules 2019, 24, x 8 of 18 
 
chain is modified to sulfenic acid, thus blocking the nucleophilic attack of the thiol to the substrate 
C6. On the contrary, in the complex with FdUMP, the thiol of Cys197 is reactive and can form a 
covalent adduct with the inhibitor that, indeed, is positioned closer to the catalytic residue. In this 
arrangement, the 5-fluorine on the FdUMP uracil moiety is proximal (~2.7 Å) to the Tyr145 hydroxyl, 
suggesting the formation of a halogen bond with it [16] (Figure 5a). Moreover, the same moiety of 
Tyr145 donates an H-bond to the FdUMP ketone oxygen in position 4, contributing to stabilize the 
inhibitor within the catalytic cavity. 
At variance with the dUMP-complex, FdUMP binding is further stabilized by 5-FTHF (Figure 
5a). Indeed, the pteridin moiety of 5-FTHF is accommodated just above the 5-fluoro-uracil of the 
substrate analogue, placing its 5-formyl substituent proximal to the FdUMP C5 (distance of ~3.2 Å). 
This configuration of the active site mimics the stage of the catalytic reaction in which the methyl 
moiety on the cofactor N5 (resulting from the aperture of the mTHF five-membered ring) is ready to 
be transferred to the substrate [9]. The structural comparison of the present ternary complex with the 
“as prepared” EfTS, where 5-FTHF alone populates the active site of one dimer subunit [5], shows 
that the binding mode of 5-FTHF is altered by bound FdUMP (Figure 5c). Notably, in the former EfTS 
structure, the catalytic Cys197 is modified to S,S-(2-hydroxylethyl)thiocyst ine by he reaction with 
β-mercaptoethanol, allowing the 5-FTHF formyl moiety to protrude in the uracil pocket (Figure 5c). 
In contrast, the binding of FdUMP to the substrate site induces a rearrangement of 5-FTHF, whose 5-
formyl group shifts by ~1.5 Å away from the inhibitor FdUMP (Figure 5c). 
 
Figure 5. (a) Active site view of EfTS (white cartoon and carbon atoms) in complex with FdUMP (in 
sticks, cyan carbons) and 5-FTHF (in sticks, dark grey carbons). In the panel, FdUMP and 5-FTHF are 
surrounded by their omit map (green mesh) contoured at the 2.5 σ level. Key interactions (salt bridges, 
hydrogen and halogen bonds) are displayed as tan dashed lines. (b) View of the active site of EfTS in 
complex with dUMP (dUMP and CSX197 in sticks, black carbons) superimposed to the EfTS-FdUMP-
5-FTHF complex (FdUMP, Cys197, and 5-FTHF in sticks, cyan carbons). (c) View of the active site of 
Figure 5. (a) Active site view of Ef TS (white cartoon and carbon atoms) in complex with FdUMP (in
sticks, cyan carbons) and 5-FTHF (in sticks, dark grey carbons). In the panel, FdUMP and 5-FTHF
are surrounded by their omit map (green mesh) contoured at the 2.5 σ level. Key interactions (salt
bridges, hydrogen and halogen bonds) are d splayed s tan dashed lines. (b) View of the active
site of Ef TS in co lex with dUMP (dUMP and CSX197 i sticks, black carbons) superimposed to
the Ef TS-FdUMP-5-FTHF complex (FdUMP, Cys197, and 5-FTHF in sticks, cyan carbons). (c) View
of the active site of the Ef TS–FdUMP-5-FTHF complex (FdUMP, Cys197, and 5-FTHF in sticks,
cyan carbons) superimposed to the substrate-free Ef TS (PDB id 3UWL, [5]; Cys197 modified as
S,S-(2-hydroxyethyl)thiocysteine, CME-197 and 5-FTHF in sticks, purple carbons). Fluorine atoms are
colored grey.
At variance with the dUMP-complex, FdUMP binding is further stabilized by 5-FTHF (Figure 5a).
Indeed, the pteridin moiety of 5-FTHF is accommodated just above the 5-fluoro-uracil of the substrate
analogue, placing its 5-formyl substituent proximal to the FdUMP C5 (distance of ~3.2 Å). This
configuration of the active site mimics the stage of the catalytic reaction in which the methyl moiety
on the cofactor N5 (resulting from the aperture of the mTHF five-membered ring) is ready to be
transferred to the substrate [9]. The structural comparison of the present ternary complex with the
“as prepared” Ef TS, where 5-FTHF alone populates the active site of one dimer subunit [5], shows
that the binding mode of 5-FTHF is altered by bound FdUMP (Figure 5c). Notably, in the former Ef TS
structure, the catalytic Cys197 is modified to S,S-(2-hydroxylethyl)thiocysteine by the reaction with
β-mercaptoethanol, allowing the 5-FTHF formyl moiety to protrude in the uracil pocket (Figure 5c).
In contrast, the binding of FdUMP to the substrate site induces a rearrangement of 5-FTHF, whose
5-formyl group shifts by ~1.5 Å away from the inhibitor FdUMP (Figure 5c).
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2.2. hTS in Complex with the Substrate dUMP and Its Analogue FdUMP
2.2.1. hTS Overall Fold
hTS was crystallized in the low-salt conditions (see Materials & Methods section; [4]), in the
presence of either dUMP or FdUMP. In both complexes, the two subunits of the hTS homodimer adopt
the active conformation, showing that Cys195 is exposed to the catalytic cavity, as occurs in previously
reported structures [3,17]. The one and half homodimers found in the ASU were fully traced, apart for
the first twenty-five N-terminal residues (and the twelve residues belonging to the non-removable
His6-tag).
2.2.2. hTS–dUMP Complex
The structure of hTS in complex with dUMP was determined to 1.95 Å resolution (Table S1),
providing a clear picture of substrate binding within the catalytic cavity (Figure 6a). The dUMP
phosphate is salt bridged to the four arginines, Arg50, Arg215, Arg175’, and Arg176’ (the last two
from the partner subunit), and it further receives an H-bond from Ser216 (Figure 6a). The dUMP
ribose hydroxyl is H-bonded to His256 to Tyr258. The uracil ketone oxygen in position 2 receives two
H-bonds from the backbone nitrogen of Asn218 and the amide nitrogen of Gln216. Nearby, the amide
of Asn226 receives an H-bond from the dUMP uracil N3 and donates one to the ketone O4. The thiol of
the catalytic Cys195 is located in an optimal position to attack the uracil C6 of the substrate (interatomic
distances ranging from 3.14 Å to 3.27 Å in the three enzyme subunits). The dUMP binding mode and
its interactions within the catalytic cavity are conserved with respect to those formerly described in
binary and ternary complexes of hTS [17].
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2.2.3. hTS–FdUMP Complex
The structure of hTS in complex with the substrate analogue FdUMP (Ki of 1.1 nM [18]) was
determined to 2.08 Å resolution (Table S1). FdUMP fully occupies the hTS active site, perfectly
mimicking the interactions entailed by dUMP in the substrate pocket (Figure 6). The 5-fluorine of
FdUMP forms an additional water-mediated interaction with the Tyr135 hydroxyl (Figure 6b). FdUMP
C6 is positioned 3.09–3.29 Å away from the Cys195 thiol, which is the same distance observed in the
dUMP complex. Former structural analysis of the hTS variant R163K, showed that FdUMP adopts
a slightly different orientation inside the substrate pocket (PDB id 3H9K [13]) (Figure 6c). Both the
ribose and the 5-fluoro-uracil moieties of FdUMP are rotated by ~40◦ with respect to the orientations
observed by us in the complex with the wt-enzyme, resulting in a remarkable loss of interactions
with the surrounding residues inside the cavity (Figure 6c). Due to this rotation, the FdUMP C6
moves away from the Cys195 thiol in the R163K variant (distance of ~4.7 Å), far from the productive
position, leading to the formation of the covalent adduct. Reasonably, the mutation of residue 163,
located ~16 Å away from the catalytic cavity, is not responsible for these changes. Additionally,
the hTS V3F variant-FdUMP complex has been reported (PDB id 3EJL [12]), showing that the substrate
analogue is rotated outside the catalytic cavity (Figure 6c). In this configuration, FdUMP is directed
towards the solvent-exposed surface of the enzyme with C6 placed ~12.0 Å away from the catalytic
cysteine. The FdUMP binding modes observed in the complexes of the above hTS variants are not
fully consistent with the mechanism of action of the inhibitor, relying on the formation of a covalent
adduct with the TS catalytic cysteine [19]. On the other hand, in our complex, FdUMP mimics the
substrate, placing its 5-fluoro-uracil C6 in an optimal position to form the covalent adduct with the
reactive thiol of Cys195.
2.3. Structural Comparison between Bacterial and the Human TSs in Complex with dUMP and FdUMP
The structures of several bacterial TS–substrate complexes have been reported in the PDB
(Escherichia coli TS, EcTS, PDB id 1BID [20]; Lactobacillus casei, LcTS, PDB id 2TDM [21]; Staphylococcus
aureus TS, SaTS, PDB id 4DQ1 (unpublished results); Mycobacterium tuberculosis TS, MtbTS, PDB id 3QJ7
(unpublished results); Corynebacterium glutamicum TS, CgTS, 4H0U (unpublished results). The sequence
alignment is displayed in Figure S2) and shows a remarkable conservation of the residues involved in
dUMP binding. Figure 7a shows the superimposition of dUMP in Ef TS, LcTS, and hTS, highlighting the
same pose of the substrate in all enzymes. At variance with the other complexes, in Ef TS, the catalytic
Cys197 is oxidized in those subunits where dUMP is bound, evidencing that the residue modification
does not alter the ability of the enzyme to accommodate the substrate. However, this explains the tiny
gain in the distance between the uracil C6 and the cysteine thiol, resulting in ~3.7 Å in Ef TS, whereas
distances of 3.2–3.4 Å characterize other bacterial TS–dUMP complexes [20,21]. In all complexes,
the four-arginine cluster, anchoring the dUMP phosphate, is highly conserved. This evidence strongly
suggests that the closure of the loop 18–26, observed in Ef TS upon dUMP binding, is important to
stabilize the substrate inside the active site.
On the other hand, a slightly different configuration is observed in the complex with the substrate
analogue FdUMP, which populates the catalytic cavity of Ef TS together with the cofactor derivative
5-FHTF (Figure 7b). The ternary complex observed in Ef TS is remarkably similar to the structure of
MtbTS in complex with FdUMP and the cofactor 5-methyl-THF (deriving from aperture of the mTHF
5-membered ring; PDB id 4FOG, unpublished results) (Figure 7b). FdUMP adopts the same binding
mode in both complexes, showing its uracil C6 positioned ~2.7 Å away from the thiol of the catalytic
cysteine (Cys197 in Ef TS, Cys146 in MtbTS). However, the 5-fluorine of the inhibitor is observed in
two different orientations, being directed towards the cofactor in MtbTS, whereas in Ef TS, it points
towards the hydroxyl of Tyr145, allowing the formation of a halogen bond with it. Conserved binding
modes also characterize the cofactor 5-methyl-THF and its analogue 5-FTHF, bound to MtbTS and
Ef TS. In each instance, the pterin N5 is positioned on top of FdUMP uracil C5. On the other hand,
a slightly different configuration inside the catalytic cavity is displayed by the analogous complexes
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(FdUMP and 5-methyl-THF) obtained with Bacillus subtilis TS (BsTS; PDB id 1B02 [22]) and E. coli TS
(PDB id 1TLS [23]). The structure of BsTS is reported in Figure 7b. In both structures, the formation of
the ternary covalent adduct is observed, resulting from the covalent anchoring of the FdUMP C6 to the
cysteine thiol and of the FdUMP C5 to the cofactor 5-methyl moiety. In the ternary covalent adducts,
both ligands are slightly distorted. In Ef TS, 5-FTHF, having a 5-formyl group that replaces the methyl
of the cofactor, acts as an inhibitor, preventing the formation of the ternary covalent adduct. Therefore,
our Ef TS-FdUMP-5-FTHF ternary complex mimics the pre-reactive step of catalysis in which both
substrate and cofactor are aligned in the cavity to allow the transfer of the pterin N-5 substituent.
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i . Active site view of the superimpos tion among the complexes: (a) Ef TS–dUMP (CSX197
in sticks, white carbon atoms; dUMP in sticks, black carbons), LcTS–dUMP (in sticks, light green
carbons; P B id 2TDM [21]), and hTS–dUMP (in sticks, pink carbons). (b) Ef TS– dUMP–5-FTHF
(Cys197 in sticks, whi e carbon atoms; ligands in sticks, cyan carbons), MtbTS–FdUMP–5-methyl-THF
(in sticks, orange carbons; PDB id 4FOG, unpublished results), and BsTS–FdUMP–5-methyl-THF (in
sticks, olive carbons; PDB id 1B02 [22]). (c) Ef TS–FdUMP–5-FTHF (white cartoon, Cys197 in sticks,
white carbon atoms; ligands in sticks, cy carbons) and hTS–FdUMP (pink cartoon and carbon atoms).
( ) Ef TS–FdUMP–5-FTHF (white cartoons, Cys197 white carbon atoms; ligands in sticks, yan carbo s)
and hTS–dUMP–raltitrexed (pink cartoon and c rbon atoms). In the (a) and (b) panels, only the
catalytic cysteine is shown in the structures of LcTS, hTS, MtbTS, and BsTS for clarity.
The structure of the Ef TS–FdUMP complex was also compared to that of the human enzyme,
evidencing the occurrence of tiny changes in the inhibitor binding mode (Figure 7c). In Ef TS,
the FdUMP 5-fluorine is close to the Tyr145 hydroxyl, forming a halogen bond with it (Figures
5a and 7c). In contrast, in the hTS complex, the FdUMP uracil is shifted far from the isostructural
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Tyr135, and a water molecule mediates its interaction with the fluorine of the inhibitor (Figures 6b and
7c). A comparison of Ef TS and hTS complexes shows that, in hTS, the orientation of His196 prevents
the inhibitor from lying closer to Tyr135, whereas in Ef TS, the sidechain of His198 (corresponding
to hTS His196) is rotated by ~70◦, allowing the direct interaction between the fluorine and Tyr145
(Figure 7c). The superimposition further evidences that FdUMP in hTS partially overlaps the cofactor
site of Ef TS. In addition, hTS Cys195 is slightly moved with respect to the position of the corresponding
residue observed in Ef TS. To explain these differences, the structure of Ef TS was compared to the that
of hTS in complex with dUMP and the cofactor analogue raltitrexed (PDB id 1HVY [3]), evidencing
that even the cofactor site is somewhat shifted in the human enzyme (Figure 7d). Notably, in Ef TS, the
indole system of Trp84, belonging to the SD, protrudes inside the catalytic cavity and establishes van
der Waals interactions with the cofactor analogue, generating a hindrance that induces a more compact
assembly of FdUMP and 5-FTHF within the active site (Figure 7d). In hTS, Asn112 matches the position
Ef TS Trp84, allowing a less tight configuration inside the catalytic cavity (Figure 7d). This tryptophan
residue of Ef TS is conserved among bacterial TSs of other human pathogens, including S. aureus,
B. melitensis, and Mycobacterium tuberculosis (Figure S2). The presence of Trp in bacterial TS versus Asn
in the active site of hTS can be of key importance for the design of selective bacterial TS inhibitors.
2.4. Conformational Transitions in EfTS and hTS Enzymes
The structural studies performed on both E. faecalis and human TS highlighted the existence
of different stable conformations that were connected to distinct functional states of the enzymes.
Even though various hypotheses have been formulated, the mechanisms behind these conformational
transitions have not been fully elucidated. In Ef TS, the open and closed states characterize the two
subunits of a single protein dimer (asymmetric homodimers), suggesting that this enzyme works
through half-site reaction mechanisms [5]. Half-site reactivity, although with much less evident
conformational changes, has also been reported for other bacterial TSs that differ in structure from
Ef TS [7,8]. On the other hand, conformational transitions are also characteristic of the human enzyme
in which the active and inactive conformations are instead concomitantly adopted by both enzyme
subunits, resulting in a symmetric homodimer.
The characterization of Ef TS in complex with dUMP provides evidence that the transition between
the open and the closed state occurs in this enzyme as a bi-phasic process. dUMP binding inside the
catalytic cavity triggers the closure of the loop 18–26, exposing Arg22 inside the catalytic site, in which
it participates in the four-arginines cluster that anchors the dUMP phosphate group. Remarkably,
the binding of the substrate does not influence the whole SD that keeps the open conformation.
Moreover, the movement of the 18–26 loop does not affect the partner subunit, where 5-FTHF is bound,
which adopts the closed conformation. The flexibility of the 18–26 loop is a peculiar feature of Ef TS;
indeed, there is no evidence of analogous rearrangements in other TS enzymes.
On the other hand, the conformational transitions that characterize hTS do not involve loop
26–54, corresponding to the Ef TS loop 18–26, which is oriented towards the catalytic cavity in both
hTS active and inactive conformations. hTS is characterized by the high flexibility of the catalytic
loop (residues 181–197) that shifts between the active and the inactive conformations. In the inactive
conformation, the catalytic Cys195 moves out from the catalytic cavity into the enzyme dimer interface.
The active conformation of the hTS catalytic loop closely resembles the orientation of the corresponding
residues 183–199 in Ef TS. It is worth noting that conformational transitions in both enzymes involve
the SD, which shifts from a flexible to ordered structure. Both the open state of Ef TS and the inactive
conformation of hTS are characterized by widely unstructured SDs, which become fully orderered
after the transition to the closed state and active conformation, respectively.
The structural comparison of these enzymes further evidences a common orientation for Gln148
in the Ef TS closed state and for the corresponding Gln138 in the hTS active conformation (Figure 8).
Notably, the side chains of both residues flip by ~180◦ following the transition to the open state and
inactive configurations (Figure 8). In the Ef TS closed state, the amide moiety of Gln148 is H-bonded
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to Asn143, Asn185, and Asp188 (Figure 8a). All these interactions are lost in the open state, in which
the side chain of Gln148 is rotated away from these residues (Figure 8a). In Ef TS, Asn185 and Asp188
belong to a loop located at the dimer interface, whose placement is also affected by the enzyme
conformational transitions. Indeed, in the open state, Gln148 rotation releases the loop 183–199,
which shifts towards the partner subunit by ~2.7 Å, whereas it is tied to Gln148 in the closed state.
Furthermore, the Ef TS residues 183–199 directly participate in the interface interaction with the partner
subunit, suggesting that they can be involved in the inter-subunit communication, regulating the
half-site reactivity that characterize this enzyme.
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Figure 8. (a) Structural superimposition between the closed (white cartoon and carbon atoms; H-bonds
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Analogously to the closed state of Ef TS, in the active conformation of hTS, Gln138 forms conserved
interactions with Pro133, Asn183, and Asp186 (Figure 8b). In contrast, the transition to the inactive
conformation induces a flip of the Gln138 amide moiety, which loses its interactions with residues
183 and 186, but forms H-bonds with the backbone of Trp181 (Figure 8b). In hTS, residues 181–197
belong to the catalytic loop, highlighting the importance of the rearrangement of the Gln138 side
chain to stabilize both conformations. It is worth noting that the portion 181–190 participates in the
dimer interface, suggesting that the mobility of the catalytic loop also mediates the inter-subunit
communication in hTS.
3. Materials and Met ods
3.1. Macromolecule Production
Ef TS was prepared according to an established procedure [5]. Human TS was expressed and
purified as previously described, with minor modifications [24]. Briefly, hTS was expressed as the
His6-tag protein (the not-cleavable N-terminal His6-tag was encoded by the pQE-80L expression
plasmid) in E. coli strain BL21(DE3). Bacteria were cultured at 30 ◦C in the auto-induction medium
ZYP-5052 [25] for 30 h. Cells, harvested by centrifugation (3000× g, 15 min, 8 ◦C), were suspended in
buffer A (50 mM HEPES, pH 7.5, and 30 mM NaCl), with the addition of 20 mM imidazole, 0.2 mM
phenylmethylsulfonyl fluoride (PMSF), and 0.5 mg mL−1 lysozyme, and then disrupted by sonication
after 60 min incubation on ice. The cell-free extract, obtained by centrifugation (12,000× g, 60 min,
8 ◦C), was applied to a HisTrap HP 5 mL column (GE Healthcare, Chicago, IL, USA) and eluted using
a 250–500 mM imidazole concentration in the same buffer. Fractions containing the target protein
were pooled and dialyzed in buffer A. The high purity (>98%) of the resulting protein sample was
confirmed by SDS-PAGE analysis and MALDI-TOF mass spectrometry.
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3.2. Enzyme Activity and Inhbition Assayes
Enzyme activity assays were performed spectrophotometrically, according to a reported
protocol [5,24]. Briefly, 1 mL reaction mixtures were prepared by adding aliquots of the enzyme
(80–120 nM) to the assay buffer (50 mM TES, pH 7.4, 25 mM MgCl2, 6.5 mM HCHO, 1 mM EDTA,
75 mM β-mercaptoethanol), including variable concentrations of dUMP (50–200 µM) and mTHF
(50–200 µM). Reactions, started by the addition of the substrate, were monitored by following the
increase in absorbance at 340 nm during the oxidation reaction of mTHF to 7,8-dihydrofolate (DHF),
for 3 min. Kinetic parameters characterized for both enzymes were in complete agreement with those
formerly reported [5,24]. Inhibition assays for FdUMP were performed under the above condition
using an enzyme concentration of 95 µM, and substrate and cofactor concentrations of 120 and 50 µM,
respectively. The inhibition data versus hTS were already reported in the literature and were confirmed
by our experiments [18]. The dose-response curve for Ef TS inhibition by FdUMP was generated by
adding compound concentrations ranging from 0.25 to 10 µM. The IC50 value, obtained by non-linear
regression fitting of the initial rates (in terms of residual enzyme activity) versus the logarithm of the
inhibitor concentrations, resulted in 0.815 ± 0.099 µM (as calculated using the software GraphPad
Prism 8, San Diego, CA, USA). Measures were performed in triplicate. The Ki value of 74 nM for
FdUMP versus Ef TS was calculated using the equation IC50 = Ki (1 + S/KM) [26] (where S and KM are
the substrate concentration and the Michaelis-Menten constant, respectively).
3.3. Protein Crystallization
3.3.1. Ef TS
Ef TS crystallization was performed using the hanging drop vapour-diffusion method [27] at room
temperature. Crystals of the complex Ef TS–dUMP were grown in drops prepared by mixing 4 µL of
sample (Ef TS 7 mg mL−1 in 25 mM phosphate buffer, pH 6.8, 100 mM dUMP, and 2 mM DTT) and
2 µL of precipitant (2.2–2.5 M ammonium sulfate and 0.1 M HEPES, pH 7.5) solutions and equilibrated
over an 800 µL reservoir. Crystals of Ef TS in complex with FdUMP were grown using the Nextal
Crystallization Tool [28]. Drops were prepared by mixing equal volumes of sample (Ef TS 7 mg mL−1
in 25 mM phosphate buffer, pH 6.8, 4 mM FdUMP, and 2 mM DTT) and the above precipitant solution
and were equilibrated over a 1 mL reservoir. Before data collection, crystals (grown within two-three
weeks) were transferred to the cryoprotectant solution (20 % vol/vol ethylene glycol, 2.5 M ammonium
sulfate and 0.1 M HEPES, pH 7.5) and flash frozen in liquid nitrogen.
3.3.2. hTS
Crystals of hTS were grown at room temperature using the hanging-drop vapor-diffusion
method [27]. Drops were prepared by mixing equal volumes of sample (hTS 20 mg mL−1 in 50 mM
HEPES, pH 7.5, 30 mM NaCl, 20 mM β-mercaptoethanol, and either 40 mM dUMP or 2 mM FdUMP)
and precipitant (27–30 % wt/vol PEG4000, 30 mM ammonium sulfate and 0.1 M TRIS, pH 9) solutions.
Crystals appeared in one to three days in drops equilibrated over an 800 µL reservoir. Before data
collection, crystals were washed in the cryoprotectant solution (20 % vol/vol PEG400, 30 % wt/vol
PEG4000, 30 mM ammonium sulfate and 0.1 M TRIS, pH 9) and flash frozen in liquid nitrogen.
3.4. Data Collection and Processing, Structure Solution and Refinement
X-ray crystallographic data were collected using synchrotron radiation at the Diamond Light
Source (DLS, Didcot, United Kingdom) beamlines I03, I04-1, and I24, equipped with either Dectris
Pilatus 6M-F or Pilatus3 6M detectors, and at the PetraIII (DESY, Hamburg, Germany) beamline
P14 on a Dectris Pilatus 6M-F detector. Reflections were indexed and integrated using the program
Mosflm [29] and scaled with SCALA [30] from the CCP4 suite [31]. Data collection and reduction
statistics are displayed in Table S1. Ef TS crystals belonged to the primitive monoclinic space group
P21, with two enzyme dimers in the cell asymmetric unit (ASU). hTS crystals are monoclinic, space
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groups C2 or I2, with three enzyme subunits in the ASU (one and half hTS dimer). In this case, one
hTS dimer sits on a space group special position of multiplicity 2 (two-fold axis).
The structures of the complexes were solved by molecular replacement using the software
Molrep [32] from the CCP4 suite. One monomer of hTS in the active conformation (PDB id 1HWY [3])
and a functional Ef TS dimer (PDB id 3UWL [5]) were used as searching models, excluding water
molecules and non-protein atoms. All structures were refined with Refmac5 [33] from the CCP4 suite
using TLS parametrization [34] in the last cycles of the refinement protocol. The optimal partitioning of
the polypeptide chains was calculated though the TLS Motion Determination web server [35], resulting
in twenty continuous segments. The molecular graphic software Coot [36,37] was used for the manual
rebuilding and modelling of missing atoms. Water molecules were added through the ARP/wARP
suite [38] and checked with Coot. In all models, the occupancies of the exogenous ligands were
adjusted to values resulting in atomic displacement parameters close to those of neighboring protein
atoms in fully occupied sites. The stereochemical quality of the final models was checked using Coot
and Procheck [39]. The overall quality of each structure has been validated though the Protein Data
Bank submission procedure. Refinement statistics are reported in Table S2. Figures were generated
using the molecular-graphic software CCP4mg [40].
3.5. PDB Deposition
Atomic coordinates and structure factors were deposited in the Protein Data Bank under
the accession codes 6QYA (Ef TS–dUMP), 6QXS (Ef TS–FdUMP), 6QXH (hTS–dUMP), and 6QXG
(hTS–FdUMP).
4. Conclusions
Enterococci are Gram-positive bacteria intrinsically resistant to various classes of
antimicrobials [41,42]. In healthy people, E. faecalis, together with E. faecium, are only responsible
for occasional urinary tract infections; however, they are deeply involved in healthcare-associated
opportunistic infections. In recent years, vancomycin-resistant E. faecalis and E. faecium have become a
serious health issue, highlighting the need to identify new antibiotics effective towards their infections.
Bacterial TS enzymes represent a validated target for the development of antimicrobial drugs. In the
past years, various classes of inhibitors have been explored for bacterial TSs, some of them specifically
targeting Enterococcus faecalis TS, such as phtalimide-derivatives [43,44]. The most active phtalimide
inhibitors of Ef TS showed selectivity towards the human counterpart enzyme [44]. Nevertheless,
much larger efforts are required to achieve effective treatments. Ef TS is characterized by a quite
peculiar behaviour, being the only bacterial TS known so far showing large asymmetry within each
enzyme dimer. This has been associated with the alternate transitions between the open and closed
states of its subunits. In this work, we provide new evidence to support the half-site reactivity model
proposed for this enzyme. Indeed, asymmetrical ligand binding is observed in Ef TS complexes
with both the substrate dUMP and its analogue FdUMP. Furthermore, these complexes provide new
important insight into the mechanism concerning the transition between the open and closed states,
providing evidence that it occurs in Ef TS as a bi-phasic process. The binding of the dUMP substrate
triggers the closure of the loop 18–26, whereas the rearrangement of the SD, required to complete the
transition to the closed state, needs the population of the cofactor site. This is particularly evident
in the complex with FdUMP, in which the settlement of the substrate pocket is accompanied by the
binding of 5-FTHF in the cofactor site. However, in Ef TS-dUMP and Ef TS-FdUMP complexes, the
concomitant population of the substrate site in both dimer subunits was not observed. The reason
behind this unique behaviour of Ef TS remains an open question.
The comparison with the analogous complexes obtained for the human enzyme highlights
meaningful differences in ligand binding. In Ef TS, Trp84 displays a major contribution to cofactor
binding, inducing a more compact assembly of the molecules in the catalytic cavity. On the other hand,
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hTS Asn112 matches the position of Ef TS Trp84, generating a rearrangement of both the cofactor and
the substrate sites inside the cavity.
The structure of Ef TS in complex with a representative phtalimide inhibitor (PDB id 4O7U [44])
showed close van der Waals contact between the six-membered aromatic ring of phtalimide and Trp84,
explaining the selectivity profile of these molecules. Trp84 of Ef TS is also conserved in TSs of other
human pathogens, such as M. tuberculosis and S. aureus, providing a clue for the design of new selective
bacterial TSs inhibitors.
Supplementary Materials: Figure S1: structural comparison of the 5-FTHF binding mode; Figure S2: Sequence
alignment among TSs from different sources; Table S1: Data collection and processing statisctics; Table S2.
Structure solution and refinement statistics.
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